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Lars O. Dragsted1*, Qian Gao1, Giulia Praticò1,2, Claudine Manach3, David S. Wishart4, Augustin Scalbert5
and Edith J. M. Feskens6Abstract: In the dietary and health research area, biomarkers are extensively used for multiple purposes. These
include biomarkers of dietary intake and nutrient status, biomarkers used to measure the biological effects of
specific dietary components, and biomarkers to assess the effects of diet on health. The implementation of
biomarkers in nutritional research will be important to improve measurements of dietary intake, exposure to
specific dietary components, and of compliance to dietary interventions. Biomarkers could also help with improved
characterization of nutritional status in study volunteers and to provide much mechanistic insight into the effects of
food components and diets. Although hundreds of papers in nutrition are published annually, there is no current
ontology for the area, no generally accepted classification terminology for biomarkers in nutrition and health, no
systematic validation scheme for these biomarker classes, and no recent systematic review of all proposed
biomarkers for food intake. While advanced databases exist for the human and food metabolomes, additional tools
are needed to curate and evaluate current data on dietary and health biomarkers. The Food Biomarkers Alliance
(FoodBAll) under the Joint Programming Initiative—A Healthy Diet for a Healthy Life (JPI-HDHL)—is aimed at
meeting some of these challenges, identifying new dietary biomarkers, and producing new databases and review
papers on biomarkers for nutritional research. This current paper outlines the needs and serves as an introduction
to this thematic issue of Genes & Nutrition on dietary and health biomarkers.
Keywords: Metabolomics, Biomarker, Nutrition, Ontology, Food intake, Classification, Validation, Databases, ReviewBackground
Introduction—biomarkers in nutrition research
Dietary and health biomarkers have been addressed in
several recent reviews [1–7]. These reviews cover vari-
ous applications of biomarkers in food, nutrition, and
health research as well as aspects of their identification,
measurement, and validation. The definition of the term
“biomarker” varies considerably. While definitions in
these papers cover specific aspects of food intake or
health effects, biomarkers are more generally defined as
“chemical or biological test results in an analysed bio-
logical material related to a certain exposure, susceptibil-
ity, or biological effect” [6]. In the Ontobee subsection
on Chemical Entities of Biological Interest (ChEBI) [8], a
biomarker is defined as “A substance used as an indica-
tor of a biological state,” clearly reflecting biomarkers as
a subcategory of “indicators.” “Indicators” are, in turn,* Correspondence: ldra@nexs.ku.dk
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the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zedefined as “anything used in a scientific experiment to indi-
cate the presence of a substance or quality, change in a
body, etc.” The ChEBI ontology therefore reflects experi-
mental science and measurement of chemical substances as
prerequisites for the use of the term, “biomarker.” However,
in nutrition research, there is widespread use of observa-
tional studies and of markers that cannot be characterized
as a substance, e.g., blood pressure, waist circumference, or
a host antibody response. While discriminating between
the terms “indicators” and “biomarkers” may be useful in
some areas of research, the overlap in their definitions and
use make this distinction less useful in nutrition research
underlining the need for a specific ontology for nutritional
science.
The distinction between different categories of bio-
markers has been underlined in several reviews in the
area. Jenab et al. [2] subdivides them into recovery, pre-
dictive, concentration, and replacement biomarkers, based
on their biokinetics and intended use. As already men-
tioned, another classification divides them into exposure,
effect, and susceptibility biomarkers, thereby focusing onlyle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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and a unifying classification scheme may therefore be
needed. This is particularly important since the discovery
of new biomarkers and their validation is clearly needed
to advance nutritional science as outlined in several recent
reviews of this area [4, 7, 9].
Biomarker validation is particularly important in order
to improve the quality of nutritional studies. However,
the reliability of a biomarker may depend on the applica-
tion, biological sample, sample collection strategy (time,
frequency), and study design. A clear distinction of
validation criteria for the different classes of biomarkers
is therefore needed.
Excellent tools and guidance exist for producing
systematic reviews and meta-analyses such as the
Cochrane handbook [10]. In addition, the PRISMA
Statement [11, 12] has been developed to assist
researchers in conducting systematic reviews of
randomized trials and interventions. When it comes
to biomarkers used as tools for measuring food intake
or assessing nutritional status, there is a need for
another paradigm because several of the steps
described for the current procedures do not apply.
Also, when it comes to sharing all of this information
in databases and associated online tools, there is a
need to build upon several of the tools already men-
tioned. These include ontologies for the subject area,
a classification scheme for biomarkers, validation
tools, and high quality reviews of the current state of
knowledge, see Fig. 1. As a project launched under
the JPI-HDHL, the FoodBAll consortium aims to
close some of these gaps through a series of reviews
in this thematic issue of the journal.
An ontology for the dietary and health biomarker area
Ontologies exist for several nutrition-related areas, in-
cluding biological chemistry [8] and environmental [8],
bioassay [13], and biomedical investigations [14]. There
is even some initial work on an ontology for nutritional
studies [15] and an ontology for food [16]. However,
most terms and relationships related to nutrition and
biomarkers are not yet covered at any of these sites.
Creating a network of defined terms with connections to
some of these ontologies is therefore a potential way
forward. It is not the intention here to formally develop
full nutrition ontology, only to define terms that can
serve as classes and subclasses in developing ontology
for this field. Figure 2 contains suggestions for terms
that could be included in such nutrition ontology and at
the same time outlines the definitions of terms used in
this thematic issue of Genes and Nutrition.
The connection of the term “food” to the simple defin-
ition in ChEBI (“Any material that can be ingested by an
organism”) is useful. However, it is a bit too broad bynot excluding ingestion of drugs or non-food objects. It
is further complicated because this ontology has orga-
nized the term as a subclass of “food component,” while
it would be more useful to have food as class term, with
food components and food compounds as subclasses as
we suggest here. In ENVO (the Environment Ontology),
the term “food product” is defined as “A substance, usu-
ally composed primarily of carbohydrates, fats, water
and/or proteins, that can be eaten or drunk by an animal
or human being for nutrition or pleasure” [8]. Defining
food products solely as substances may be confusing in
chemistry-related fields such as nutrition and food
chemistry, so using the term “material” to define food
should be preferred. Since many non-foods such as
drugs could be ingested “for pleasure,” the definition is
also a bit too broad and the complex practices, fre-
quency, or reasons for ingesting foods should be
avoided in the definition. Therefore, in simplicity, any
material may be considered a food as long as it is in-
herently able to sustain nutrition to some extent. The
preferred definition of food for nutrition and health sci-
ence would therefore be “Any material or substance
that can be ingested by an animal or human for nutri-
tion.” The subclasses of “food products” in ENVO
should also be subclasses of “food” and “food group”
thereby linking downstream to the various single foods
and food components for which biomarkers of intake
should ideally be found.
Nutrition, as such, is not found as a term in any
ontology yet while “nutritional science” is an undefined
class term with no subclasses under biomedical science
in EMBRACE [17]. A broad definition of nutritional
science suggested here is “The science of all processes
by which organisms take in and utilise nutrients or
other food components,” while nutrients could be de-
fined as “Food compounds needed to maintain a living
organism.” Note that nutritional science as defined here
also embraces non-nutrient components in the food
since these compounds may have considerable influ-
ence on the health effects of foods. This is also the case
for public definitions such as the one found in Wikipe-
dia, “Nutrition is the science that interprets the inter-
action of nutrients and other substances in food in
relation to maintenance, growth, reproduction, health
and disease of an organism” [18]. Food intake and
nutrition are closely related therefore making “diet” a
natural link between the food science terms and the nu-
trition area. In this case, “diet” may therefore in this
context be defined as “The combination of foods
consumed by an individual or a group within a certain
time period.” By defining these terms and linking them
with existing ontologies, dietary and health biomarkers
can now be discussed on the basis of a coherent set of
terms.
Fig. 1 A schematic overview of a framework supporting the development of dietary biomarkers. Ontology and classification scheme serve as the
tools to navigate the targeted class of biomarkers. For each specific class of biomarkers, literature search would be conducted to provide reviews
of the current state of knowledge on putative biomarkers. Putative biomarkers may also be identified by new explorative research. Candidate
biomarkers are selected from the putative biomarkers by removing implausible entries based on literature. A validation scheme is applied on the
candidate biomarkers to assess their validity by a defined set of criteria to identify the most promising candidate biomarkers as partially or fully
validated for a specified use. Further validation studies may be used to systematically validate the best candidate biomarkers. All the available
information is shared in public databases to support further studies on the development of biomarkers
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There are a number of biomarkers that may belong to
several of the classes described by Biesalski et al. [6], i.e.,
they can be used as exposure, effect, or susceptibility
biomarkers, depending on the study purpose and design.
Several of the exposure biomarkers measured in plasma,
which are termed concentration and replacement bio-
markers by Jenab et al. [2], may be used to assess expo-
sures to nutrients or contaminants. However, for some
of these compounds such as vitamins, minerals, or heavy
metals, there are also established thresholds for minimal
or maximal concentrations beyond which there is an in-
creased risk of deficiency (for vitamins and minerals) or
toxicity. When biomarkers are used to compare sample
concentrations with such limits, they are actually usedto assess the status, vulnerability, or even risk of an indi-
vidual and, hence, should be classified as susceptibility
biomarkers. Clearly, the classification in these cases is
more dependent on the intended application of the mea-
surements than on the methodology as such. Exposure
biomarkers in urine have been termed recovery bio-
markers if the full dose may be recovered. Alternately,
they are called predictive biomarkers if only a fraction is
excreted [2]. If a dietary treatment is used to improve
absorption of a nutrient, then this marker becomes re-
lated to response rather than exposure or susceptibility.
Most metabolites measured in urine may therefore qual-
ify in each of the major classes, depending on the
purpose of the measurements and study design. For ex-
ample, p-cresol sulfate along with other metabolites
Fig. 2 Proposed terms for initiating ontology for the dietary and health biomarker area
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however, this compound is also formed endogenously by
our microbiota. Formation is clearly affected by the
composition of the diet in terms of omnivorous and
vegetarian diets and hence may be said to reflect dietary
intake [19]. On the other hand, p-cresol formation may
also affect sulfation capacity so its sulfate ester may be a
marker of altered metabolism (effect) or residual cap-
acity (susceptibility) [20]. Additionally, p-cresol sulfate
has been shown to be a susceptibility marker related to
risk of progressing kidney disease [21]. In other words,
p-cresol sulfate as a biomarker could have at least three
different classifications, depending on the intended use.
Many other exposure biomarkers, including omega-3 fatty
acids, beta-carotene, and choline metabolites also reflect
some degree of functional change or host factor capacity
leading to similar biomarker classification ambiguity.
Other examples, some of which will be discussed below,
include measurements of blood pressure, blood glucose,
and hippuric acid. Biomarker ambiguity, whether bio-
chemical, anthropometric, or physiological, is thereforequite common, as many combine elements of two or three
of the exposure, effect, and susceptibility marker classes.
Biomarkers are typically affected by a combination of
exposures and host factors and consequently complex to
interpret, resulting potentially in controversy. Blood pres-
sure may serve as an illustrative example. It is well estab-
lished today that blood pressure is influenced by genetic
(host) factors and genetic variation may be involved in 50
% of the population variability [22]. Blood pressure is also
affected by dietary and lifestyle exposures, including exer-
cise [23], smoking [24], and healthy eating [25]. While re-
lationships with risk of stroke and coronary disease is
quite clear, health-related effects of blood pressure within
the normal range from 120/80 to − 90/60 mmHg are not
equally clear and a large variation in what constitutes an
optimal blood pressure may exist on an inter-individual
basis [26]. Moreover, the measurement is very sensitive to
the protocol and repeated measurements should be done
by the same person. Care must therefore be exercised in
study planning and in interpretation when blood pressure
is used as a marker, and it should be clear whether it is
Dragsted et al. Genes & Nutrition  (2017) 12:24 Page 5 of 7used for determining risk or effect. In analogy to blood
pressure, there is a range of biochemical and physiological
biomarkers where only the high and low ends of the out-
come scale are readily interpreted in terms of individual
risk, e.g., most anthropometric measures, hormones, micro-
nutrients, intermediary metabolites, and cognitive scales.
An important consequence of this ambiguity is that
validation of a biomarker may depend on its use. Most
validation schemes can roughly be subdivided into ana-
lytical performance and biological interpretability. The
analytical performance of a biomarker may often be in-
dependent of the study design and purpose. However,
this is clearly not the case when the measurement of ex-
tremes is more important than the normal range for bio-
logical reasons. For instance, the detection limit or
linear range of a method may suffice for an assessment
of baseline characteristics but not for the assessment of
an extreme response or vice versa. For instance, the use
of glucose monitors may reflect variation with sufficient
precision to follow the change in response in individuals
during an OGTT or dietary test (i.e., used as an effect
biomarker), while the accuracy of the same method
would not suffice to determine fasting glucose levels for
diagnostic purposes (i.e., as a risk or susceptibility bio-
marker). Validation of biomarker measurements may
therefore depend on the biomarker class, which in turn
may depend mainly on its intended use. Validation
schemes taking into consideration the intended applica-
tions of dietary and health biomarkers are therefore
needed in order to help validate the large number of
new potential biomarkers resulting from the many ex-
plorative (“omics”) investigations on diet and health.
Analysis of the literature for assessing biomarker validity
Putative new biomarkers of dietary exposures and of
dietary effects on health are being published at a rapid
pace as a result of recent developments in metabolomics
[4, 27], but previous work through the last 40+ years has
also pointed to a number of potentially important diet-
ary biomarker compounds identified by more traditional
approaches. Some of these have been “re-discovered” by
metabolomics. This calls for standards for doing system-
atic literature searches and for evaluating biomarker
candidates. Standards for systematic reviews and meta-
analyses already exist for effect markers, including the
Cochrane guidelines [10]. The PRISMA statement [11]
also helps to assess many aspects of individual study
quality in order to weigh their importance for an overall
conclusion. These aspects relate to the strength of the
experimental or observational designs, the quality of re-
cruitment, the randomization procedures, etc. The aim
of these guidelines are to critically assess effects reported
in human studies and they are not aimed at assessing
methodological studies or performing systematic reviewsfor food and dietary intake biomarkers. Guidelines devel-
oped specifically for assessing the literature on bio-
markers are therefore needed. The aim should be to find
previously suggested biomarkers and to critically assess
their quality. Moreover, the evaluation of each biomarker
candidate should be supported by the literature search
strategy by including different quality aspects. The vision
for this work on intake biomarkers would be:
(a) to identify and evaluate existing putative intake
biomarkers for all food groups based on the
literature,
(b)to validate the more promising candidates using a
coherent quality assessment scheme, and
(c)to create a database including all suggestive food
intake biomarkers along with their current level of
validity for assessing exposure.
This should support further work on food intake bio-
marker development and validation by pointing out the
studies needed to improve the assessment of validity.
Moreover, such a system should help researchers to as-
sess the quality of food intake biomarkers that are con-
sidered for use in human studies on diet and health.
Similar literature search guidelines, quality assessment
tools, and validation schemes need also to be developed
for susceptibility and effect biomarkers.Supporting databases for food intake biomarkers
Biomarker development for research in nutrition and
health is dependent on resources to quickly find infor-
mation on compounds in foods and on food intake bio-
markers proposed by others. The literature review and
validation of biomarkers for all major food groups
should therefore be entered into searchable database
structures along with unique identifiers. The most com-
prehensive databases on food constituents and their
chemical and biological data are FooDB (www.foodb.ca)
[28], the expert-curated database PhytoHub (www.phy-
tohub.eu) [29] focused on dietary phytochemicals, and
the Phenol-Explorer database on polyphenols [30].
These databases are currently being enriched to include
new data on food non-nutrients and their human metab-
olites. The added metabolites will include the known
metabolites described in the literature as well as in silico
predicted metabolites, thereby covering large numbers
of potential biomarkers for food intake. In parallel, a
new database called Exposome-Explorer (exposome-
explorer.iarc.fr) is being developed to include all known
dietary biomarkers and rich information on their meas-
urement in various populations [31]. Exposome-Explorer
will thereby supplement information in the human me-
tabolome database [32].
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tral importance to help researchers annotate findings
from metabolite profiling studies. In many cases, the
compounds measured as biomarkers are not commercially
available and information on their (bio)synthesis and avail-
ability in non-commercial laboratories for sharing can be
found in FoodComEx (Food Compound Exchange, food-
comex.org) [33]. FoodComEx is designed as an online
catalog of pure compounds, which have been made avail-
able by academic laboratories. Exchange of compounds
with a provider depends on bilateral agreements on the
terms of collaboration. Rules for these collaborations have
been defined in a charter of good practices. FoodComEx is
a collaborative initiative widely open to new contributors
and users.
Another web resource developed in the FoodBAll pro-
ject is a web portal (foodmetabolome.org) [34]. This por-
tal is continuously updated to present links to the most
useful tools, databases, libraries of spectra, and software
for nutritional metabolomics as well as for dietary bio-
marker discovery. The portal will be further developed
to present tutorials, webinars, and news related to the
food metabolome and to food intake biomarkers.
Conclusions
The current pace of biomarker discovery and biomarker
applications is higher than ever before due to the rapid
development of “omics” technologies and data collec-
tion. This rapid development may reshape future re-
search in nutrition and health. In order to support this
development, there is a need to develop ontologies for
food, nutrition, and diet-related health areas. There is
also a need to classify biomarkers in such a way that sys-
tematic attempts to validate them and develop them into
trusted research tools is possible according to standard-
ized criteria and according to their intended use. Finally,
there is a need for improved methods to systematically
search both older and more recent literature for the best
biomarkers for foods, food groups, and food constituents
and to develop and support database systems to include
updated information on the validity of biomarker mea-
surements for different applications. All of these aspects
are addressed in this special issue of Genes and Nutri-
tion by partners of the FoodBAll consortium.
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